跳至主要内容
临床试验/NCT07826845
NCT07826845招募中不适用

Body Donation in HHT

University Hospital, Essen1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2025年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
5
试验地点
1
主要终点
Differences in immune and endothelial cells in tissue with and without telangiectasia in HHT

研究概览

简要总结

The possibility of body donation in hereditary hemorrhagic telangiectasia (HHT) means that human tissue samples with and without vascular malformations can be analyzed. The aim is to gain insights into the disease mechanism.

详细描述

HHT is also known as Osler's disease or Rendu-Osler-Weber syndrome and is inherited in an autosomal dominant manner. With a prevalence of 1 in 5,000 - 10,000 people, it is one of the relatively common rare diseases. In terms of molecular biology, affected individuals have a disorder of physiological angiogenesis, resulting in pathological vascular connections, so-called arteriovenous malformations. In principle, vascular changes in the context of HHT can affect all organ systems, but there are various predilection sites such as the skin and mucous membranes, liver, lungs, gastrointestinal tract and brain.

In preliminary work, we were able to show that in addition to the known mutations in the TGFβ signaling pathway, further trauma or previously unknown events must occur locally in order for the vascular short circuits to form. However, the exact disease mechanisms are still unclear. Obtaining human tissue samples is difficult due to ethical concerns (taking samples from living patients could lead to a worsening of the disease). The aim of this project is to analyze structural changes in tissue samples with and without vascular malformations.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • positiv genetic testing for HHT and/ or at least three fulfilled Curacao Criteria
  • older than 18 years

排除标准

  • missing inclusion criteria

研究组 & 干预措施

HHT Patients

Other

Patients with HHT

干预措施: body donation in HHT (Other)

结局指标

主要结局

Differences in immune and endothelial cells in tissue with and without telangiectasia in HHT

时间窗: after the patients who gave informed consent died their body will be donated to the Institute of Anatomy of the University Hospital Essen, samples will be taken until the body is cremated (regularly within 12 months)

Analysis of the differences in tissue with and without telangiectasia in HHT, e.g. immunfluorescence staining of tissue / bone with endoglin-/ alk 1- antibodies and quantitative analysis of endoglin/ alk1 lacking cells such as immune cells or endothelial cells

次要结局

未报告次要终点

研究者

发起方
University Hospital, Essen
申办方类型
Other
责任方
Principal Investigator
主要研究者

Freya Droege

PD Dr. med. Freya Droege, Principle Investigator

University Hospital, Essen

研究点 (1)

Loading locations...

相似试验